ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued on Thursday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

The company has a market cap of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. ObsEva has a 52 week low of $0.08 and a 52 week high of $2.14. The stock has a fifty day simple moving average of $0.01.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.